Correlation Between Ginkgo Bioworks and Entero Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Entero Therapeutics,, you can compare the effects of market volatilities on Ginkgo Bioworks and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Entero Therapeutics,.

Diversification Opportunities for Ginkgo Bioworks and Entero Therapeutics,

0.53

Correlation Coefficient

Ginkgo Bioworks  Entero Therapeutics,

Very weak diversification

The 3 months correlation between Ginkgo and Entero is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Ginkgo Bioworks and Entero Therapeutics,

Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to generate 1.01 times more return on investment than Entero Therapeutics,. However, Ginkgo Bioworks is 1.01 times more volatile than Entero Therapeutics,. It trades about 0.07 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.09 per unit of risk. If you would invest  1,070  in Ginkgo Bioworks Holdings on October 10, 2024 and sell it today you would earn a total of  50.00  from holding Ginkgo Bioworks Holdings or generate 4.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.24%
Values	Daily Returns

Ginkgo Bioworks Holdings  vs.  Entero Therapeutics,

Ginkgo Bioworks Holdings

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point.

Entero Therapeutics,

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ginkgo Bioworks and Entero Therapeutics,

The main advantage of trading using opposite Ginkgo Bioworks and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.

The idea behind Ginkgo Bioworks Holdings and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.